Monopar Therapeutics (MNPR) Misses Q1 EPS by 46c

Monopar Therapeutics (NASDAQ: MNPR) reported Q1 EPS of ($0.46).

For earnings history and earnings-related data on Monopar Therapeutics (MNPR) click here.

You May Also Be Interested In

• Science Applications Int'l (SAIC) Tops Q2 EPS by 70c
• EU naval forces board oil tanker suspected of Russia ties
• Gap (GAP) Reiterated at Buy by UBS as EPS Growth Rate Expected to Inflect Positiively